Results for "Genetic Disorder"
Conditions Encyclopedia Entry 1775864409
Cystic fibrosis is a rare, genetic disorder characterized by the buildup of thick, sticky mucus in the lungs, pancreas, and other organs, leading to recurrent infections, lung damage, and digestive problems.
Health & MedicineConditions Encyclopedia Entry 1779319400
** **Hypertrophic Cardiomyopathy (HCM)** is a genetic disorder that affects the heart muscle, leading to thickening of the heart walls, which can impair the heart's ability to pump blood effectively. **CONTENT** ### Overview Hypertrophic Cardiomyopathy (HCM) is a complex and potentially life-threatening heart condition that affects approximately 1 in 500 people worldwide. It is characterized by the thickening of the heart muscle, particularly in the left ventricle, which can lead to impaired heart function and increased risk of sudden cardiac death. HCM is often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. The symptoms of HCM can vary widely, and many people may not experience any noticeable symptoms at all. However, common symptoms include chest pain, shortness of breath, fatigue, and dizziness. In some cases, HCM can lead to more severe complications, such as heart failure, arrhythmias, and sudden cardiac death. Early detection and treatment are crucial in managing HCM and preventing long-term complications. ### History/Background HCM was first described in the early 20th century, but it wasn't until the 1970s and 1980s that the condition gained more attention. In 1979, Dr. Barry Maron and his colleagues published a seminal paper on HCM, which helped to raise awareness of the condition and its potential risks. Since then, significant advances have been made in understanding the genetic and molecular mechanisms underlying HCM, as well as the development of new diagnostic and treatment strategies. ### Key Information HCM is caused by mutations in genes that code for proteins involved in the structure and function of the heart muscle. The most common genes associated with HCM are MYBPC3, MYH7, and TNNT2. These mutations can lead to abnormal thickening of the heart muscle, which can impair the heart's ability to pump blood effectively. Diagnosis of HCM typically involves a combination of clinical evaluation, electrocardiogram (ECG), echocardiogram, and cardiac MRI. In some cases, genetic testing may be recommended to identify the underlying genetic mutation. Treatment of HCM depends on the severity of the condition and the presence of symptoms. In mild cases, lifestyle modifications such as regular exercise and a healthy diet may be sufficient. In more severe cases, medications such as beta blockers and anti-arrhythmics may be prescribed to manage symptoms and prevent complications. In some cases, implantable cardioverter-defibrillators (ICDs) may be recommended to prevent sudden cardiac death. ### Significance HCM is a significant public health concern, particularly among young athletes and individuals with a family history of the condition. Early detection and treatment are crucial in preventing long-term complications and improving outcomes. The development of new diagnostic and treatment strategies has improved our understanding of HCM and its management. **INFOBOX** - **Name:** Hypertrophic Cardiomyopathy - **Type:** Genetic disorder - **Date:** 1979 (first described) - **Location:** Global - **Known For:** Thickening of the heart muscle, impaired heart function, and increased risk of sudden cardiac death **TAGS:** Hypertrophic Cardiomyopathy, Heart Condition, Genetic Disorder, Cardiac Disease, Sudden Cardiac Death, Heart Failure, Arrhythmias, Cardiac MRI, Echocardiogram, Electrocardiogram, Genetic Testing.
Health & MedicineConditions Encyclopedia Entry 1780390384
** A rare genetic disorder characterized by the abnormal expansion of **CTG repeats** in the **DMPK gene**, leading to progressive muscle weakness, atrophy, and other systemic complications. **CONTENT:** ### Overview Myotonic Dystrophy Type 1 (DM1) is a complex, inherited neuromuscular disorder affecting approximately 1 in 8,000 individuals worldwide. It is the most common form of myotonic dystrophy, accounting for about 80% of cases. The condition is characterized by progressive muscle wasting, **myotonia** (difficulty relaxing muscles after contraction), and other systemic features such as cataracts, heart conduction defects, and cognitive impairment. DM1 is a genetic disorder caused by an abnormal expansion of **CTG repeats** in the **DMPK gene**, which is located on chromosome 19. The expanded repeats lead to the production of a toxic protein that disrupts normal muscle function and contributes to the development of the disease. The condition is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to cause the disease. ### History/Background The first reported case of myotonic dystrophy dates back to 1909, when Swedish neurologist Ragnar Vogt described a patient with progressive muscle weakness and **myotonia**. However, it wasn't until the 1960s that the genetic basis of the disease was identified. In 1992, the **CTG repeat expansion** in the **DMPK gene** was found to be responsible for the condition. Since then, significant advances have been made in understanding the molecular mechanisms underlying DM1 and developing treatments to manage its symptoms. ### Key Information * **Symptoms:** Progressive muscle weakness, **myotonia**, cataracts, heart conduction defects, cognitive impairment, and other systemic features. * **Genetics:** Autosomal dominant inheritance, caused by an abnormal expansion of **CTG repeats** in the **DMPK gene**. * **Diagnosis:** Clinical evaluation, genetic testing (PCR or Southern blot), and electromyography (EMG) to confirm the diagnosis. * **Treatment:** Management of symptoms with medications, physical therapy, and lifestyle modifications; no cure is currently available. * **Prognosis:** Variable, depending on the severity of the disease and the individual's overall health. ### Significance Myotonic Dystrophy Type 1 is a significant condition that affects not only the individual but also their family members, who may be at risk of inheriting the mutated gene. The condition highlights the importance of genetic counseling and testing for individuals and families affected by inherited disorders. Research into DM1 has also led to a greater understanding of the molecular mechanisms underlying neuromuscular diseases and the development of new treatments for other conditions. **INFOBOX:** - **Name:** Myotonic Dystrophy Type 1 (DM1) - **Type:** Genetic disorder - **Date:** 1909 (first reported case) - **Location:** Worldwide - **Known For:** Progressive muscle weakness, **myotonia**, and other systemic complications **TAGS:** Myotonic Dystrophy, Neuromuscular Disorder, Genetic Disorder, **CTG Repeat Expansion**, **DMPK Gene**, **Myotonia**, Muscle Weakness, Cataracts, Heart Conduction Defects, Cognitive Impairment.
Health & MedicineConditions Encyclopedia Entry 1780290029
Hypertrophic cardiomyopathy (HCM) is a genetic disorder that affects the heart muscle, leading to abnormal thickening of the heart walls and potentially life-threatening complications.
Health & MedicineConditions Encyclopedia Entry 1777594865
Cystic fibrosis (CF) is a **genetic disorder** that affects the **respiratory**, **digestive**, and **reproductive systems**, causing thick, sticky mucus to build up in the lungs, digestive tract, and other areas of the body.